Showing results (1-10 of 23) with videos related to
Sort By:
Pageof 3
International Journal of Cancer|August 16, 2014
Oncometabolites-driven tumorigenesis: From genetics to targeted therapyAurélie Morin, Eric Letouzé, Anne-Paule Gimenez-Roqueplo, et al.Cell and Tissue Research|February 11, 2018
Rodent models of pheochromocytoma, parallels in rodent and human tumorigenesisCharlotte Lussey-Lepoutre, Alexandre Buffet, Aurélie Morin, et al.Current Topics in Medicinal Chemistry|October 29, 2009
Systemic delivery and quantification of unformulated interfering RNAs in vivoAurélie Morin, Catherine Gallou-Kabani, Jacques R R Mathieu, et al.Transcription|February 16, 2013
Of mice and men: fuzzy tandem repeats and divergent p53 transcriptional repertoiresAurélie Morin, Boris Bardot, Iva Simeonova, et al.Plos Genetics|July 5, 2012
Fuzzy tandem repeats containing p53 response elements may define species-specific p53 target genesIva Simeonova, Vincent Lejour, Boris Bardot, et al.Plos One|October 11, 2007
SIRNA-directed in vivo silencing of androgen receptor inhibits the growth of castration-resistant prostate carcinomasDaniel Compagno, Carole Merle, Aurélie Morin, et al.Oncotarget|September 9, 2017
Establishment of a mouse xenograft model of metastatic adrenocortical carcinomaAurélie Morin, Carmen Ruggiero, Estelle Robidel, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 11, 2011
Identification of CAD as an androgen receptor interactant and an early marker of prostate tumor recurrenceAurélie Morin, Lauriane Fritsch, Jacques R R Mathieu, et al.Plos One|August 11, 2012
Risk of hormone escape in a human prostate cancer model depends on therapy modalities and can be reduced by tyrosine kinase inhibitorsCharlotte Guyader, Jocelyn Céraline, Eléonore Gravier, et al.Science Signaling|March 9, 2017
Dosage-dependent regulation of VAV2 expression by steroidogenic factor-1 drives adrenocortical carcinoma cell invasionCarmen Ruggiero, Mabrouka Doghman-Bouguerra, Silviu Sbiera, et al.Pageof 3